Immuneering Corp. (IMRX)

6.08 -0.12 (-1.94%) USD  |  NASDAQ  |  Dec 12, 16:00
6.095 +0.02 (+0.25%) After-Hours: 20:00
More

Immuneering Total Expenses (% of Annual Revenues)

Total Expenses (% of Annual Revenues) Chart

View Total Expenses (% of Annual Revenues) for IMRX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Expenses (% of Annual Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Expenses (% of Annual Revenues) Range, Past 5 Years

View Total Expenses (% of Annual Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (% of Annual Revenues) Benchmarks

View Total Expenses (% of Annual Revenues) Benchmarks
Start Trial
Amgen, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade
Fortress Biotech, Inc. Upgrade
BridgeBio Pharma, Inc. Upgrade